AU2002216847A1 - Epitopes of pai-1 - Google Patents
Epitopes of pai-1Info
- Publication number
- AU2002216847A1 AU2002216847A1 AU2002216847A AU1684702A AU2002216847A1 AU 2002216847 A1 AU2002216847 A1 AU 2002216847A1 AU 2002216847 A AU2002216847 A AU 2002216847A AU 1684702 A AU1684702 A AU 1684702A AU 2002216847 A1 AU2002216847 A1 AU 2002216847A1
- Authority
- AU
- Australia
- Prior art keywords
- pai
- epitopes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8132—Plasminogen activator inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10053251.9 | 2000-10-26 | ||
DE2000153251 DE10053251A1 (en) | 2000-10-26 | 2000-10-26 | New protein or peptide comprising epitope of plasminogen activator inhibitor-1, useful for screening substance for treating thromboembolic and cardiovascular diseases, cancer or related diseases |
DE2001110235 DE10110235A1 (en) | 2001-03-02 | 2001-03-02 | New protein or peptide comprising epitope of plasminogen activator inhibitor-1, useful for screening substance for treating thromboembolic and cardiovascular diseases, cancer or related diseases |
DE10110235.6 | 2001-03-02 | ||
PCT/BE2001/000186 WO2002034776A2 (en) | 2000-10-26 | 2001-10-25 | Epitopes of pai-1 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002216847A1 true AU2002216847A1 (en) | 2002-05-06 |
Family
ID=26007505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002216847A Abandoned AU2002216847A1 (en) | 2000-10-26 | 2001-10-25 | Epitopes of pai-1 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002216847A1 (en) |
WO (1) | WO2002034776A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2652131A1 (en) | 1999-04-09 | 2000-10-19 | Rigshospitalet | Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker |
US7374886B2 (en) | 1999-04-09 | 2008-05-20 | Rigshospitalet | Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer |
GB0405033D0 (en) * | 2004-03-05 | 2004-04-07 | Karobio Ab | Novel pharmaceutical compositions |
WO2005094863A1 (en) * | 2004-03-30 | 2005-10-13 | Den Kgl.Veterinær-Og Landbohøjskole | Improvements in cancer treatment and cancer treatment efficacy prediction by blocking and decting protease inhibitors |
RU2301678C1 (en) * | 2006-05-30 | 2007-06-27 | Общество С Ограниченной Ответственностью "Сиа Пептайдс" | Peptide stimulating regeneration of central nervous system neurons, pharmaceutical composition based on thereof and method for its using |
US8507436B2 (en) | 2007-07-24 | 2013-08-13 | D-Pharm Ltd. | Peptides derived from plasminogen activator inhibitor-1 and uses thereof |
ES2770507T3 (en) * | 2013-08-13 | 2020-07-01 | Sanofi Sa | Antibodies directed against plasminogen activator inhibitor type 1 (PAI-1) and uses thereof |
TW201722994A (en) | 2013-08-13 | 2017-07-01 | 賽諾菲公司 | Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and uses thereof |
MX2016010852A (en) | 2014-02-21 | 2016-10-26 | Astellas Pharma Inc | New anti-human pai-1 antibody. |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1030679A4 (en) * | 1997-10-17 | 2003-03-05 | Univ Pennsylvania | Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
-
2001
- 2001-10-25 AU AU2002216847A patent/AU2002216847A1/en not_active Abandoned
- 2001-10-25 WO PCT/BE2001/000186 patent/WO2002034776A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002034776A3 (en) | 2004-01-08 |
WO2002034776A2 (en) | 2002-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002254570A1 (en) | Epitope sequences | |
AU2002323381A1 (en) | Deodorant composition | |
AU2001264256A1 (en) | Plaster | |
AU2001260327A1 (en) | Chair | |
AU2002225730A1 (en) | Compounds | |
AU2001233691A1 (en) | Antiperspirant compositions | |
AU2001252679A1 (en) | Plaster | |
AU2001267707A1 (en) | Antiperspirant formulations | |
AU2001293728A1 (en) | Cosmetic composition | |
AU2001285790A1 (en) | Antiperspirant compositions | |
AUPQ661800A0 (en) | Insulin-potentiating compounds | |
AU2002217071A1 (en) | Novel use of polyhydroxy compounds | |
AU2002216847A1 (en) | Epitopes of pai-1 | |
AU2002225724A1 (en) | Motilide compounds | |
AU2002218278A1 (en) | Water-selective cementing composition | |
AU2001242342A1 (en) | Antiperspirants | |
AU2001267693A1 (en) | Antiperspirant formulations | |
AU2001275201A1 (en) | Acne-treating composition | |
AU2002217285A1 (en) | Compounds | |
AU2001287852A1 (en) | Composition | |
AU2001252200A1 (en) | Chair | |
AU2002221132A1 (en) | Novel antibody | |
AU2002358649A1 (en) | Antiperspirant composition | |
AU2001287732A1 (en) | Copolycarbonate-based composition | |
AU2001262163A1 (en) | Composition |